TV News LIES

Wednesday, Mar 29th

Last update05:20:13 AM GMT

You are here News Health Study outcome won't sway company on eye drug

Study outcome won't sway company on eye drug

E-mail Print PDF

What does a company do when there's anecdotal evidence that two of its drugs are equally effective in treating a leading cause of blindness in the elderly, one costing patients $60 per treatment and the other $2,000?

In the case of Genentech Inc., nothing.

The company declined to seek federal approval for the cheaper drug, Avastin, to treat the wet form of age-related macular degeneration. Nor would it help finance _ or cooperate with _ a National Eye Institute study comparing the effectiveness and safety of Avastin, a cancer drug, and the more expensive eye drug, Lucentis.

More...


Most Recent Related Stories...


Computer program can diagnose, locate cancer from blood test

Computer program can detect and locate cancerResearchers have developed a computer program that can detect cancer and identify its location using a...

AARP, American Medical Association oppose GOP health care bill, citing loss of coverage

AARP, AMA oppose GOP health planTwo major interest groups with sway among Capitol Hill lawmakers have come out forcefully against the...

Former 49ers receiver Dwight Clark announces ALS diagnosis

Dwight Clarke has ALSSan Francisco 49ers legendary receiver Dwight Clark announced Sunday he has been diagnosed with ALS."I have...

House GOP releases plan to repeal, replace Obamacare

Paul Ryan health planCongressional Republicans on Monday night released their formal plan for replacing Obamacare. The bill calls for issuing...
 
America's # 1 Enemy
Tee Shirt
& Help Support TvNewsLIES.org!
TVNL Tee Shirt
 
TVNL TOTE BAG
Conserve our Planet
& Help Support TvNewsLIES.org!
 
Get your 9/11 & Media
Deception Dollars
& Help Support TvNewsLIES.org!
 
The Loaded Deck
The First & the Best!
The Media & Bush Admin Exposed!